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Cardiovascular Diseases (CVDs) are the primary source of global mortality and 
morbidity. The initial steps of CVD development occur in the endothelium. 
MicroRNAs (miRNAs) have recently emerged as novel regulators of cardiovascular 
physiology and pathology. Interestingly, regular aerobic exercise acts to prevent 
CVDs and also regulates miRNAs in the circulation (ci-miRNAs). The purpose of 
this study was to determine the effects of serum from highly active and sedentary, 
young, healthy individuals on migration rate of endothelial cells in vitro. Secondarily, 
CVD-associated ci-miRNAs in serum were compared between groups. The results of 
this study represent a novel way by which sedentary behavior may act as an early risk 
for CVD development before the appearance of other classic risk factors. RT-qPCR 
array analysis identified nine ci-miRNAs as > 4-fold differentially expressed in serum 
of trained versus inactive subjects, though more subjects are needed before any 
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 Atherosclerosis is the number one cause of death worldwide, and by 2030 it is 
projected that over 43% of Americans will be living with some form of 
cardiovascular disease (CVD) (Mathers and Loncar, 2006; Fuster et al., 2007; Go et 
al., 2014). Unrepaired injury to the endothelium results in endothelial dysfunction, 
and this represents the first step in the atherogenic process underlying the majority of 
CVD cases (Levy, 1981; Lusis, 2000; Vanhoutte, 2010). Early identification and 
prevention of endothelial dysfunction is, therefore, of great clinical interest. Physical 
inactivity is a well-recognized independent risk factor for development of CVD 
(Powell et al., 1987; Fletcher et al., 1996; Beaglehole et al., 2007). Alternatively, 
regular exercise confers a protective effect against CVD, with research showing a 
40% reduction in risk among highly active individuals (Shiroma and Lee, 2010). 
Beneficial cardiovascular adaptations to exercise training include increased aortic 
compliance, enhanced ventricular performance (Moore and Korzick, 1995), increased 
capillarization and arterial enlargement (remodeling) (Brown, 2003), and enhanced 
endothelial vasodilation and function (Hambrecht et al., 2003). A comprehensive 
understanding of the molecular mechanisms responsible for these protective 
adaptations, however, remains to be fully elucidated.  
MicroRNAs (miRNAs) are ~22 nucleotide long non-coding RNAs that 
modulate gene expression by post-transcriptional regulation of specific mRNA 
targets. There are over 2,500 miRNAs encoded in the human genome that act on the 




MiRNAs exert their control by associating with a protein complex and binding to 
complementary mRNAs, usually causing either translational repression or mRNA 
decay by a variety of mechanisms. Owing to the complexity of miRNA gene 
silencing, a single miRNA may target several mRNAs, while multiple miRNAs can 
also regulate the same mRNA. Of interest, several miRNAs enriched in various cell 
types, including endothelial cells, have been shown to regulate physiological and 
pathological processes such as endothelial function, dysfunction, and every stage of 
atherosclerosis (Madrigal-Matute et al., 2013; Santoro and Nicoli, 2013; Sun, Belkin 
and Feinburg, 2013). Thus, clinical treatment of CVDs by miRNA therapy is of great 
interest, and this concept has already been validated in animal models (Lanford et al., 
2010; Loyer et al., 2014).  
Recently it was discovered that endothelial cells, along with many other cell 
types, can release miRNAs into circulating blood both passively and actively 
(Fichtlscherer, Zeiher, and Dimmeler, 2011; Mcmanus and Ambros, 2011). Some of 
these circulating miRNAs (ci-miRNAs) are dysregulated in CVD states and have 
emerged as useful clinical biomarkers (Olson, 2014). Additionally, ci-miRNAs have 
been shown to be taken up by endothelial cells, where they play important roles in 
regulating endothelial processes (Finn and Searles, 2012). For example, migration of 
endothelial cells is vital to angiogenesis and wound healing of the endothelium, with 
deficiencies in this process potentiating endothelial dysfunction and atherogenesis 
(Ettenson and Gotlieb, 1993; Gimbrone et al., 2000; Lamalice, Le Boeuf, and Huot, 
2007). Jansen et al. showed that in response to injury, miR-126 contained in 




recipient endothelial cells where it promotes endothelial repair by cell migration 
(2013). This response is decreased in CVD patients, who exhibit reduced ci-miRNA-
126 levels (Jansen et al., 2013).  
Likewise, human umbilical vein endothelial cells (HUVECs) exposed to 
physiological levels of laminar shear stress in vitro  have displayed enhanced wound 
healing by cell migration (Albuquerque et al., 2000; Mun, Jang, and Boo, 2013). 
Indeed, laminar shear stress has been shown to influence secretion of miRNAs from 
HUVECs in vitro (Hergenreider et al., 2012), while it also regulates endothelial cell 
function through altering levels of intracellular miRNAs (Boon, Hergenreider, and 
Dimmeler, 2012). High shear stress has been shown to up-regulate miRNA-21 in 
HUVECs (Weber et al., 2010), which was subsequently recognized to modulate cell 
migration (Sabatel et al., 2011). MiRNA-92a is down-regulated by shear stress, while 
treatment with its antagonist (antagomir-92a) prevented endothelial dysfunction and 
decreased atherosclerosis in mice fed a high-fat diet, displaying the promising 
potential of miRNA therapy (Loyer et al., 2014). Repeated bouts of elevated vascular 
shear stress is a primary factor mediating the beneficial effects of exercise on the 
endothelium (Brown, 2003; Hambrecht et al., 2003; Whyte and Laughlin, 2010), 
suggesting that the in vivo effects of exercise on ci-miRNA and endothelial migration 
may be similar to those of shear stress applied in vitro.  
Regular exercise has undisputed favorable effects on the endothelium and 
vasculature as a whole (Brown, 2003). As well as decreasing risk of CVD, regular 
exercise improves endothelial function and reverses dysfunction through a variety of 




(Green et al., 2003; Di Francescomarino et al., 2009). Research suggests that 
circulating factors in the blood may be partially responsible for these observed 
beneficial effects. For example, a 3-week training program reduced the potency of 
serum from chronic heart failure (CHF) patients to induce endothelial cell death in 
vitro (Mammi et al., 2011). Furthermore, serum collected from athletes promoted 
endothelial cell uptake of EMP which was associated with enhanced migration in 
vitro compared to endothelial cells cultured with growth medium alone (Wahl et al., 
2014).  
Recently, several studies have shown differential expression of intracellular 
and ci-miRNAs following both acute exercise and exercise training (Baggish et al., 
2011; Makarova et al., 2014; Nielson et al., 2014), while Gan et al. showed higher 
expression of miRNA-499 in muscle of active individuals at rest compared to a 
healthy, sedentary group (2013). Intriguingly, circulating levels of miRNA-499 are 
also elevated in acute coronary syndrome patients, and are associated with 
cardiomyocyte injury (De Rosa et al., 2011; Kuwabara et al., 2011). Similarly, 
endurance training increased cardiac miRNA-126 expression in rats, as compared to 
sedentary controls, which was possibly related to exercise-induced cardiac 
angiogenesis (Da Silva et al., 2012). Examples of ci-miRNAs regulated by exercise 
and training also include those shown to be involved in vital endothelial cell 
processes such as angiogenesis (Baggish et al., 2011).  
However, the influence of ci-miRNAs on the endothelium is poorly 
understood. Despite evidence of a favorable ci-miRNA signature associated with 




stress on miRNAs involved in endothelial cell migration, no study has examined the 
potential ci-miRNA induced differences in migration as a result of a highly active 
versus sedentary lifestyle. Therefore, we proposed to compare the migration rate of 
endothelial cells cultured with serum from regularly exercising versus sedentary 
subjects. Furthermore, we aimed to elucidate ci-miRNAs potentially responsible for 
the hypothesized differences in serum’s effect on endothelial cell migration rate as a 
result of exercise training status. We hypothesized that exercise-training induced 
secretion of circulating factors, such as ci-miRNAs, contributes to endothelial 
adaptations and cardiovascular benefits. The results of this research will be of 
substantial public health and clinical significance, as uncovering ci-miRNAs involved 
in the development of endothelial dysfunction may provide novel targets for the 
prevention and/or treatment of CVDs.  
 
 
Specific Aim 1: To determine cell migration rate differences in HUVECs due to 
aerobic exercise training-mediated effects on serum.  
Hypothesis 1: Serum of subjects who regularly engage in aerobic exercise will cause 
HUVECs to have a higher migration rate as compared to serum of their inactive 
counterparts. 
 
Specific Aim 2: To identify ci-miRNAs that are differentially expressed between 
the highly active and inactive groups that could potentially be responsible for 
altered cell migration rate associated with exercise training status.  
Hypothesis 2: Group differences in endothelial cell migration rate will be associated 






Subjects: Men and women between the ages of 20-39 were recruited for participation. 
All subjects gave written informed consent prior to taking part in the study, which 
was approved in advance by the University of Maryland IRB. Subject characteristics 
were acquired as part of a previous study (Landers-Ramos et al., 2015). Participants 
were placed into groups based on self-reported level of habitual endurance exercise 
over the past 5 years. Endurance-trained/highly active subjects (n=10) reporting >4 
days/week or >4 hours/week of moderate intensity aerobic exercise (including 
competition) were matched by age and BMI with inactive counterparts (n=10), who 
reported <20 min/day and <2 days/week of exercise. Height and weight were 
obtained for calculation of BMI. Body fat percentage was determined using the 7-site 
skinfold procedure (Jackson and Pollock, 1978) and VO2max was measured via a 
maximal graded treadmill test. Blood chemistry was examined for a number of CVD 
risk factors. Exclusion criteria included: systolic blood pressure ≥ 130 mmHg, 
diastolic blood pressure ≥ 90mmHg, fasting glucose ≥ 100 mg/dl, serum total 
cholesterol ≥ 200 mg/dl, low-density lipoprotein ≥ 130 mg/dl, and high-density 
lipoprotein ≤ 35 mg/dl. All women were tested during the follicular phase of their 
menstrual cycle to control for the effects of estrogen. 
Serum Collection and Storage: Sample collection was performed as previously 
described (Landers-Ramos et al., 2015). In brief, blood was collected by cubital vein 
phlebotomy into non-coated tubes and allowed to sit for at least 30 minutes to allow 




minutes at 4○C to separate serum, which was immediately frozen in 200-500 μl 
aliquots at -80○C. All blood sampling occurred after an overnight fast (~12 hours) and 
16-24 hours following each subject’s normal exercise routine in the highly active 
group. 
Endothelial Cell Migration Assay: HUVECs were initiated from cryopreserved 
aliquots and passed once before use. Once harvested from culture, HUVECs (P3) 
were re-suspended in endothelial growth medium (EGM-2, Lonza) and seeded onto 
the RadiusTM 96-well cell migration plate (Cell Biolabs, San Diego, CA) at a 
concentration of 30,000 cells per well. Plates were cultured at 37○C, 5% CO2 until 
HUVECs reached 80% confluency. At this point the media was removed and 
replaced with a gel removal solution for 30 minutes, followed by multiple washes 
with EGM-2 without fetal bovine serum (FBS). EGM-2 without FBS plus 10% serum 
was then added for each subject. The 10% serum concentration was chosen based on 
the fact that it induced the fastest rate of migration in a dose-response experiment 
(data not shown). Serum from subjects was studied in triplicate (i.e. 3 wells per each 
condition). Control wells were cultured with EGM-2 without either FBS or human 
serum, and exhibited no migration after 24 hours (data not shown). Pictures were 
taken manually using a microscope at 10x magnification immediately (0 hr) upon 
addition of samples. Migration was tracked by taking pictures every 4 hours for up to 
24 hours. The outer edge of migrating cells was traced and the area was quantified at 
each time point using ImageJ (NIH). Pictures were coded so that quantification was 




based on percentage of wound closure over time (100 – (size of wound area at time 
point / size of initial wound area x 100)).  
MiRNA Isolation: Ci-miRNA was purified from serum samples using the miRNeasy 
Serum/Plasma kit (Qiagen). First, 200 μl of serum was mixed with QIAzol lysis 
reagent and chloroform. Following centrifugation, the upper aqueous layer containing 
RNA was extracted, mixed with ethanol, and applied to the RNeasy MinElute spin 
column for several more centrifugation steps. The resulting purified total RNA 
containing miRNA was eluted in 14 μl RNase free water. Additionally, prior to 
addition of chloroform, a synthetic spike-in control (C. elegans miR-39 (cel-miR-39), 
Qiagen) was added as an internal control for extraction efficiency analysis and 
normalization of real time quantitative polymerase chain reaction (RT-qPCR) data.  
MiRNA Array: Three samples were chosen from each group to be investigated in the 
miRNA array based on their performance in the migration assay. The three fastest 
migrating samples over all time points were from trained individuals, while the three 
slowest were from inactive subjects. Thus, RNA from these subjects was pooled for 
each group and 2 μl was reverse transcribed using the miscript II RT kit (Qiagen).  
The miScript SYBR Green PCR Kit (Qiagen) was used to detect and quantify the 
expression of miRNAs by means of RT-qPCR performed on an Applied Biosystems 
7300 Real Time PCR system (Applied Biosystems, Foster City, CA). Prior to use in 
the array, cDNA samples were checked for quality using the miRNA QC PCR Array 
(SABiosciences, Frederick, MD), which includes probes to assess miRNA recovery, 
reverse transcription performance, and PCR performance. The Human Cardiovascular 




of 84 miRNAs previously implicated in CVD pathologies. The array included cel-
miR-39 primer assays for internal normalization. A web-based analysis tool was used 
to analyze the array data (Qiagen, GeneGlobe Data Analysis Center). This tool first 
calibrated the CT values based on recovery of cel-miR-39 and then normalized to the 
average of the five most invariant miRNAs between the groups. Fold-difference was 
calculated to express the difference in expression between groups using the 2-ΔΔCT 
method of relative quantification.  
Individual ci-miRNA RT-qPCR Assays: MiRNA-specific primer assays (Qiagen) 
were used to analyze ci-miRNA expression in all samples. Targets for examination 
were chosen based on those showing at least a 4-fold difference in the array, in 
combination with results of previous studies on exercise training and ci-miRNAs. The 
miRNA exhibiting the least difference between groups in the array (miR-210) was 
selected as a control. Spike-in control cel-miR-39 was quantified in each sample and 
used to calibrate expression of each ci-miRNA. Groups were compared using the      
2-ΔΔCT method of relative quantification (relative to respective cel-miR-39 CT values). 
Statistical Analysis: Statistical Analysis Software (SAS) was used for the cell 
migration and individual miRNA RT-qPCR data analyses. For the HUVEC migration 
assay, a two-way repeated measures ANOVA was used with time and activity status 
as factors. Independent t-tests were used for each ci-miRNA PCR assay. Significance 






Subject Characteristics: Subject demographics are detailed in Table 1. The exercise 
trained group consisted of 6 women and 4 men (n=10) and the inactive group 
included 5 women and 5 men (n=10). There were no significant differences in age or 
BMI between groups (p>0.05). However, the exercise trained subjects had a 52% 
higher relative VO2max (p<0.001) and 55% lower body fat (p<0.01) compared to the 
inactive group, confirming the differences in self-reported training status. All subjects 
exhibited healthy blood profiles (e.g. resting blood pressure, glucose, and cholesterol) 
and were non-smokers with no known risk factors for CVD (besides sedentary 





























Table 1. Subject characteristics 
 
  Trained  Inactive  
n 10 10 
Age, y 27.7 ± 5.5 28 ± 4.9 
BMI, kg/m2 21.5 ± 1.7 23.5 ± 2.8 
Body Fat, % 11.4 ± 4.6 20 ± 5.4* 
Absolute VO2max, ml/min 3901 ± 846 2533 ± 710.4* 
Relative VO2max, ml·kg
-1·min-1 62.4 ± 5.6 36.7 ± 6* 
SBP, mmHg 119.7 ± 5.6 121.9 ± 13.8 
DBP, mmHg 72.6 ± 6 79.6 ± 6.2* 
MAP, mmHg 88.3 ± 4.4 93.7 ± 8.1 
Glucose, mg/dl 84.2 ± 6.3 82.9 ± 9.7 
Cholesterol, mg/dl 172.7 ± 24.9 170.3 ± 30 
HDL-C, mg/dl 65.3 ± 12.9 55.3 ± 16.3 
LDL-C, mg/dl 93.2 ± 20.5 99.8 ± 25.4 
VLDL-C, mg/dl 14.2 ± 4.7 15.2 ± 6.1 
TC/HDL 2.7 ± 0.5 3.3 ± 0.9 
LDL/HDL 1.5 ± 0.4 2 ± 0.8 




Values are reported as mean ± SEM. n, number of subjects; VO2max, maximal 
volume of oxygen consumption; SBP, systolic blood pressure; DBP, diastolic blood 
pressure; MAP, mean arterial pressure; HDL-C, high-density lipoprotein cholesterol; 
LDL-C, low-density lipoprotein cholesterol; VLDL-C, very low-density lipoprotein 







Endothelial Cell Migration: Representative images of the migration assay can be seen 
in Figure 1. HUVECs exposed to serum from endurance trained individuals migrated 
8% more in the first 4 hours (p<0.05) and 13% more after 8 hours (p=0.058) 
compared to those exposed to serum from inactive subjects (Figure 2). Following 12, 
16, and 24 hours, migration was 20% (p=0.055), 19% (p>0.05), and 21% (p=0.08) 




Figure 1. Representative images of HUVEC migration due to serum from one 
endurance trained and one inactive subject. Images are 4, 12, and 24 hours following 
addition of serum and initiation of migration. The 24 hour image for the trained 










Figure 2. Quantification of HUVEC migration upon application of serum from 
endurance trained (n=10) or inactive (n=10) individuals over 24 hours. Migration was 
calculated as (100 – (size of wound area at time point / size of initial wound area x 
100)). Images were taken at 10X magnification and area was quantified using imageJ 
(NIH). Values are reported as mean + SD. *p≤0.05, statistically significant difference 
from inactive group at that time point. 
 
MiRNA Array: Of the 84 miRNA targets investigated, 71 showed appropriate 
abundance for analysis (CT ≤ 35). CT values were first calibrated based on recovery of 
spiked-in cel-miR-39.  Reverse transcription and PCR control primer assays indicated 
acceptable performance for analysis (data not shown). The data were further 
normalized using the five most invariant miRNAs between groups in the array (miRs-
210, 122, let-7c, 424, and 100). The average of the CT values for these five miRNAs 
was used for the ΔΔCT calculations. The 2
-ΔΔCT method of relative quantification was 




value for the trained sample over that of the inactive sample. Fold-difference values 
less than 1, indicating lower expression in the trained sample, were transformed to 
negative values by taking the inverse (i.e. 1 / fold-difference value). MiRNAs 
showing >4-fold difference between groups were said to be differentially expressed. 
One miRNA was more highly expressed in the trained sample, while eight where 
higher in the inactive sample (Figure 3). Those miRNAs and their respective fold-
differences (trained group/inactive group) are miR-31-5p (300.7), miR-125a-5p (-
4.7), miR-140-5p (-20.3), miR-145-5p (-5.6), miR-199a-5p (-7.4), miR-208b-3p (-






Figure 3. Analysis of CVD-related miRNAs in an RT-qPCR array. Total RNA from 
serum of three subjects per group was isolated, pooled, and reverse transcribed. 
Complimentary DNA from groups was then compared using a RT-qPCR array of 
CVD-related miRNAs. A total of 71 miRNAs showed appropriate abundance for 
analysis (Ct≤35) in both the pooled, trained and inactive cDNA samples. Expression 
is represented as the common logarithm of the 2-ΔΔCT value for the trained sample / 
that of the inactive sample. Those miRNAs exhibiting ≥4-fold difference between 
groups were considered differentially expressed. In addition, miRs-210, 126 and 222 


















Validation of Differentially Expressed ci-miRNA: The coefficient of variation for the 
CT values of the cel-miR-39 spike-in control was 2.6% (Figure 4), which is in line 
with a previous study (Rosjo et al 2014). None of the ci-miRNA targets chosen for 
analysis in all samples exhibited different expression between the groups (Figure 5). 





Figure 4. Recovery of cel-miR-39 spiked in during the isolation step was determined 
in all samples by RT-qPCR. A low variation in RNA extraction from all samples was 


















Figure 5. Individual miRNA RT-qPCR analyses in all samples using specific primer 
assays. Each point represents an individual subject (solid dots, men; striped dots, 
women) and lines represent group means. No significant differences were observed 

























 To our knowledge, this is the first study to compare the effects of serum from 
trained and inactive individuals on endothelial cells in a migration assay. In 2013, 
Beijer and colleagues determined human serum’s ability to stimulate HUVEC 
proliferation in vitro both before and after a six week resistance training program and 
found no difference due to training. Wahl et al. previously examined the effects of 
serum collected from trained triathletes and cyclists on human coronary artery 
endothelial cells in a scratch migration assay (2014). Serum accelerated migration as 
compared to control growth medium, however there were no differences seen with 
serum collected at rest or following a single 180 minute acute bout of cycling 
exercise. In our study, EGM-2 without serum was used as a control condition and did 
not induce a migration response (i.e. 0% migration). In line with our hypothesis, 
serum of inactive subjects induced a slower migration rate than that of trained 
individuals. HUVECs cultured with ‘trained serum’ migrated significantly faster at 
the 4 hour time point, and trended toward significance in the same direction at almost 
all other time points (Figure 2). This suggests circulating factor(s) in serum of 
endurance trained individuals may beneficially stimulate especially the initial stages 
involved in endothelial cell migration, though later mechanisms may be affected as 
well (Gotlieb and Lee, 1999).  
Considering both groups consist of young, healthy individuals devoid of other 
classic CVD risk factors, our results suggest a potential early effect of exercise 
training to preserve endothelial integrity. It is likely that the difference in migration 




CVD risk factors or overt CVD. For example, HUVECs cultured in the presence of 
serum from CHF patients released more lactate dehydrogenase and displayed greater 
DNA fragmentation, signs of cell death and apoptosis respectively, compared to age-
matched controls (Mammi et al., 2011). Following three weeks of fairly intensive 
physical rehabilitation, both markers were reduced, though not to levels seen in 
healthy controls. It is also important to note that the controls in that study were 
labeled ‘healthy’ despite the presence of dyslipidemia, hypertension, and/or diabetes.  
 For our study, we attempted to isolate the effects of exercise training by 
recruiting young, healthy individuals who differed only in their aerobic physical 
activity habits (Table 1). Thus, it is likely that the trained group differed from the 
inactive group only through endurance exercise training-induced mechanisms (i.e. 
exposure to regular increases in vascular shear stress). Aerobic exercise training has 
been shown to improve endothelial function and reverse dysfunction in young and 
old, healthy and diseased populations (Higashi et al., 1990; Desouza et al., 2000; 
Hambrecht et al., 1998). Improvements in endothelial function following exercise 
training are in large part attributed to increased bioavailability and/or signaling of NO 
(Di Francescomarino et al., 2009). In a study of CHF patients, the correction of 
endothelial dysfunction due to training corresponded to improvements in basal NO 
formation in the resistance arteries (Hambrecht et al., 1998). The authors of this study 
further postulated that because the vascular smooth muscle cells did not show any 
alterations in response to exogenous NO, the improvement in endothelial function 
was due to shear-stress-induced release of endothelial-relaxing factors (Hambrecht et 




stress due to exercise training beneficially increase endothelial NO production and 
decrease oxidative stress through mechanotransduction-induced pathways (Di 
Francescomarino et al., 2009). Furthermore, both shear stress and NO have been 
shown to play important roles in the regulation of endothelial processes such as 
angiogenesis, endothelial cell migration, and wound repair (Ziche et al., 1994; 
Murohara et al., 1998; Lee et al., 1999; Li, Huang, and Hsu, 2005). As shown by 
Wahl et al. though, a prolonged bout of acute exercise did not alter serum’s effect on 
endothelial cell migration, independent of shear stress (2014). There are, in fact, 
myriad other factors that may influence endothelial cell migration in one way or 
another. Further, the relatively ephemeral shear stress-mediated mechanotransduction 
effects would not likely explain longer-term differences in serum of trained versus 
inactive populations at rest. For instance, in 2012, Conti et al. observed differences in 
serum oxidative markers and NO levels in different types of athletes 15 days after the 
last bout of exercise. When they cultured endothelial cells with the serum, they found 
higher survival and proliferation rates as a result of the aerobically trained athletes’ 
serum compared to the two more anaerobically trained athlete groups (Conti et al., 
2012). This suggests an exercise training effect on circulating factors in serum, 
independent of the acute effects of elevated laminar shear-stress. A 15 day period 
without exercise is likely to induce effects of de-training, however (Coyle et al., 
1984), so these results may have depicted de-training effects on/of serum, as opposed 
to an accurate depiction of the exercise trained state. For our study, blood was 




immediate, short-term effects of elevated shear stress, while still maintaining the 
effects of exercise training. 
 As mentioned, endothelial cell migration is a highly regulated process. In 
addition to hemodynamic factors, it is modulated by numerous soluble molecules and 
intracellular pathways (Gotlieb and Lee, 1999; Dimmeler, Dernbach, and Zeiher, 
2000; Lamalice et al., 2007). Most notably, vascular endothelial growth factor 
(VEGF) potently regulates endothelial cell migration, primarily through binding to 
the cell receptor VEGFR-2 and stimulating multiple signaling pathways (Lamalice et 
al., 2007). Interestingly, at rest, circulating levels of VEGF and similar angiogenic 
factors involved in endothelial cell migration appear to be unaffected by endurance 
exercise training status (Kraus et al., 2004; Landers-Ramos et al., 2014; Lamalice et 
al., 2007). Conversely, miRNAs are strikingly mutable in response to aerobic exercise 
training (Nielson et al., 2014; Wardle et al., 2015). Many intracellular and ci-miRNAs 
are regulated by shear stress and can also modulate endothelial cell migration (Boon 
et al., 2012; Jae et al., 2015; Mondadori et al., 2015; Sabatel et al., 2011). Ci-miRNAs 
from several origins, such as monocytes, EPCs, and endothelial cells are incorporated 
by the endothelium and subsequently stimulate migration or play other 
atheroprotective roles (Zhang et al., 2010; Sahoo et al., 2011; Zernecke et al., 2009). 
In a recent study, HDL isolated from CHF patients was co-cultured with human aortic 
endothelial cells (Riedel et al., 2015). Compared to HDL from healthy controls, CHF 
HDL induced significantly less endothelial expression of pro-angiogenic miRs-126, 
21, and 222 (Riedel et al., 2015). This difference was attenuated following a moderate 




effects of HDL from other serum factors, it is interesting nonetheless since HDL are 
also known to transport miRNAs to endothelial cells, where they influence gene 
expression (Tabet et al., 2014). We thus sought to investigate differences in serum ci-
miRNAs between endurance trained and inactive subjects. 
 In our initial screening, we chose to use an array of miRNAs previously 
shown to regulate and/or respond to a variety of CVDs in humans. Several of these 
miRNAs have additionally been observed as markers of exercise and/or training. 
Analysis of 84 miRNAs in the array produced 71 targets observable within the 
detectable range for both groups (CT ≤ 35) (Figure 3). From this total, nine miRNAs 
showed ≥ 4-fold difference between groups, of which eight displayed lower 
expression in the trained group. Baggish et al. previously examined ci-miRNA levels 
in men before and after a 90 day aerobic exercise training program (2011). They 
assessed eight ci-miRNAs, five of which were previously shown to be involved in 
angiogenesis (Baggish et al., 2011). Of these, miRs-20a, 221, and 222 were elevated 
at rest following training. In a more robust examination, Nielson and colleagues 
screened for all miRNAs present in the circulation of men and compared ci-miRNA 
profiles before and after 12 weeks of cycling training (2014). They found a total of 13 
differentially expressed ci-miRNAs, 11 of which were downregulated following the 
training protocol (Nielson et al., 2014).  
MiRNAs are postulated to play a role in exercise training-induced adaptations. 
There is ample evidence that unique miRNAs are involved in the left ventricular 
hypertrophy response to aerobic exercise training, as opposed to those active in the 




Ramasamy et al., 2015). Similarly, in rats, cardiac miR-126 and ventricular capillary-
to-fiber ratio increased as a function of exercise training intensity (Da Silva et al., 
2012). The authors of this study further provided evidence for, and proposed a 
mechanism by which miR-126 downregulates inhibitors of the VEGFR-2 signaling 
pathway, leading to increased cardiac angiogenesis (Da Silva et al., 2012). In humans, 
ci-miRNAs that correlate with VO2max, running speed at lactate threshold, and 
thickness of intraventricular septum have been identified (Mooren et al., 2014). 
Moreover, plasma miRNAs have been shown to differ between elite strength and 
endurance athletes (Wardle et al., 2015). Both elite athlete groups were further 
compared to a third inactive control group, although CVD risk factors were not 
examined (Wardle et al., 2015). Of the 14 ci-miRNAs examined, four were higher in 
endurance athletes than strength athletes, and only miR-222 was different between all 
groups (Wardle et al., 2015). 
Ours is the first study, to our knowledge, to cross-sectionally compare the ci-
miRNA signatures of endurance trained and inactive individuals, with an emphasis on 
all subjects being healthy with no CVD risk factors. We chose to study a subset of ci-
miRNAs identified as ≥ 4-fold differentially expressed in the array, plus two others 
commonly seen in the CVD and exercise literature (miRs-126 and 222; 2.5- and 3.75-
fold lower in our trained group, respectively (Figure 3)). The miRNA exhibiting the 
least difference between groups in the array, miR-210, was used as a control. Ci-mir-
210 is a marker of atherosclerosis and has previously been shown as unresponsive to 
aerobic exercise training (Raitoharju, Oksala, and Lehtimaki, 2013; Baggish et al., 




all samples, no significant differences were seen (Figure 5). However, this is likely 
due to normal variability of ci-miRNA expression and the fact that we chose to study 
both men and women. Even in studies of diseases, where ci-miRNA expression is 
dysregulated, large inter-individual differences in both the disease and control groups 
are common (Vasu et al., 2014; Han et al., 2015). Indeed, in a recent review, wide 
variation in ci-miRNA expression was noted as one of the major challenges of 
defining them as useful biomarkers of CVDs (Min and Chan, 2015). 
Our data also suggest possible sex-based differences and thus render our 
sample sizes too small to draw any conclusions. Virtually all studies reporting altered 
ci-miRNA expression in association with exercise training in healthy populations thus 
far have studied only men.  Conversely, in a study using whole blood from men and 
women, Backes et al. observed no significant differences in ci-miRNAs between elite 
endurance athletes and moderately active controls (2014). Interpreting the results of 
this study raises several considerations, however. For one, the whole blood miRNA 
profile includes the intracellular miRNAs from all cells in circulation and, therefore, 
does not reflect the ci-miRNA profile of serum or plasma. Further, the control group 
consisted of healthy, age- and sex-matched “moderately active controls”, although the 
exact activity/training habits were not reported and only maximal workload achieved 
on a cycling test was measured as an indicator of training status. Though subjects 
were described as healthy, no blood chemistry analyses or other CVD risk factors 
were reported. In addition, the elite endurance trained group competed at an 
international/Olympic level, so most likely exhibited performance-related genetic 




matched individuals with the same physical activity habits separated into high and 
low VO2max groups, exhibit differential ci-miRNA expression (Bye et al., 2013). 
Further differences were also seen by separating out men and women (Bye et al., 
2013). Though more subjects are needed for any conclusive statements, our data 
similarly suggest possible sex-based differences. Since our groups also display 
significantly different VO2max values due to the effects of exercise training, it would 
be interesting to compare our results to those of Bye et al. following the recruitment 
of more subjects.  
In conclusion, we have identified a novel phenomenon by which aerobic 
exercise training enhances the ability of serum to stimulate endothelial cell migration. 
This highlights a potential early risk factor for CVD development in sedentary, 
otherwise healthy, young people. We have also identified a potential role for 
differential regulation of ci-miRNAs in the cardiovascular response to exercise 
training. Though we have postulated ci-miRNAs as mediators of this response, other 
circulating factors should not be ruled out. Future studies are needed in order to 
identify the factor(s) involved so that potential early biomarkers and/or interventions 
can be developed. Furthermore, more subjects will be recruited to supplement the 
data presented here in the hopes of elucidating training- and sex-dependent effects on 








The cardiovascular system  
 The mammalian cardiovascular system consists of the heart, blood vessels, 
and blood. The heart is a muscular pump which creates the pressure necessary to 
move blood through the closed circuit of blood vessels. Blood travels from the heart 
through the arterial system, into capillaries associated with all tissues of the body, and 
back to the heart through the veins. Vessels on the arterial side are considered the 
resistance vessels because they largely control blood pressure by vasomotion, while 
those on the venous side are considered capacitance vessels due to their distensibility. 
Capillaries consist almost exclusively of a single layer of endothelial cells and are, 
therefore, ideal for the vital exchange of small molecules between the blood and 
tissues. Indeed, all blood vessels are lined on the luminal side by this single layer of 
endothelial cells known as the endothelium. The endothelium was once thought to act 
only as a passive barrier between the blood and tissues, but is now known to play a 
variety of essential physiological roles in maintaining homeostasis. 
 Blood is made up of plasma (water), cells (red blood cells, leukocytes, 
platelets, etc.), and other circulating factors (hormones, proteins, cholesterol, etc.). 
Thus, the circulatory system is responsible for maintaining life by transporting 
oxygenated blood from the lungs to muscle and other cells for the production of 
energy and, conversely, transporting carbon dioxide (CO2) and other waste products 
from the cells for excretion. It acts to integrate all tissues of the body by providing a 




Additionally, the cardiovascular system regulates pH balance, body temperature, and 
immune function. Therefore, preserving proper cardiovascular function is of great 
importance to maintenance of healthy life.  
 
Cardiovascular disease  
A long term disturbance in normal homeostasis of the cardiovascular system 
leads to the development of disease. Cardiovascular disease (CVD) is the world’s 
leading cause of mortality, accounting for 17.3 million deaths per year (Mozaffarian 
et al., 2015). Likewise, in the United States, CVD is the underlying cause of about 1 
of every 3 deaths and >1 of every 3 adults lives with at least one CVD, presenting a 
major economic burden (Mozaffarian et al., 2015). By 2030, yearly global deaths 
from CVD are projected to rise to over 23 million (Mathers and Loncar, 2006) and 
total costs of the diseases are predicted to reach $918 billion (Mozaffarian et al., 
2015). It is clear that improving our understanding of CVD pathologies for the 
purposes of developing prevention and treatment methods is of paramount 
importance. To this end, much is known about the risk factors that potentiate CVD 
development. Traditional risk factors include aging, family history of CVD, cigarrete 
smoking, high blood pressure, impaired fasting glucose, dyslipidemia, obesity, and 
sedentary lifestyle (Mozaffarian et al., 2015; Yusuf et al., 2001). All of these factors 
act to increase risk of CVD via direct and indirect atherogenic effects on the 
endothelium. (Hadi, Carr, and Suwaidi, 2005; Bonetti, Lerman, and Lerman, 2002; 






Atherosclerosis is a disease of the arteries and is the underlying cause of 
several other CVDs, such as coronary heart disease (CHD) and chronic kidney 
disease, as well as the majority of clinical cardiovascular events (Mozaffarian et al., 
2015). Atherogenesis, the development of atherosclerosis, is a silent process with no 
overt signs or symptoms, often until the occurrence of a potentially life-threatening 
acute event. CHD is the leading cause of mortality in the U.S., alone accounting for 
about half of all CVD deaths (Mozaffarian et al., 2015). The study of atherosclerosis 
pathology stems to the 1800’s and was most notably advanced in 1856 by Rudolf 
Virchow, who postulated that atherosclerotic lesions were a response to inflammatory 
injury to the vessel wall (Ventura, 2000; Ross, Glomset, and Harker, 1977). However, 
owing to the concealed nature of the atherogenic process, CHD was only first 
reported in 1912 (Levy, 1981), despite evidence of atherosclerotic plaques in 
Egyptian mummies that lived almost 4000 years earlier (Allam et al., 2011). This 
fairly recent discovery of CHD is in large part due to the prolonged lifespan of 
humans since the threat of infectious diseases was effectively nullified as the leading 
cause of mortality (Fuster et al., 2007). As a result, CVD has only relatively recently 
become an epidemic, spreading from predominantly wealthy classes and developed 
countries in the 1920s (Levy, 1981), to developing nations and the less affluent 
(Global Status Report on Noncommunicable Diseases, 2010). Still, the complex 
molecular and cellular details of the pathologic process of atherogenesis continue to 




 Impressively, Virchow was correct in that atherosclerosis is a progressive 
inflammatory disease of the arteries developed in response to injury, though his 
hypothesis has since been modified (Ross et al., 1977; Lusis, 2000). The initiating 
injury of atherosclerosis refers to denudation of endothelial cells from the 
endothelium, which, if unabated and combined with continuous exposure to injurious 
agents (risk factors) leads to endothelial dysfunction (Ross, 1999; Francis and Pierce, 
2011). Impaired ability of the endothelium to function normally, results in 
unfavorably increased permeability, adhesiveness, and altered release of vasoactive 
molecules. Impaired vasodilation is a hallmark sign of endothelial dysfunction and 
atherosclerosis (Francis and Pierce, 2011). Continued inflammatory response to 
endothelial dysfunction results in the development of lesions, primarily in the large 
and medium sized arteries. The earliest ‘fatty streak’ lesions are commonly seen in 
the aorta of infants and children (Ross, 1999; Lusis, 2000). Lesions advance as the 
atherogenic process continues over decades until a lesion grows large enough to 
impede blood flow in an artery, or an acute rupture/erosion leads to thrombosis and 
complete occlusion of a vessel. Such events are often debilitating and/or life 
threatening (e.g. angina, myocardial infarction (MI), stroke, etc.).  
 
Endothelial function  
Maintaining a healthy, properly functioning endothelium is of utmost 
importance due to the central role of endothelial dysfunction in the atherogenic 
process. As mentioned, the endothelium consists of a single intraluminal layer of 




barrier between blood and the underlying body tissues. Far from existing solely as a 
passive barrier, the endothelium is now considered the largest organ in the body 
(Gimbrone et al., 2000; Endemann and Schiffrin, 2004; Eckers and Haendeler, 2015). 
In a healthy state, the endothelium is a dynamic network that regulates vascular tone, 
hemostatic and fluid balance, vascular permeability, vessel wall hypertrophy, immune 
function, and formation of new vessels (Smith and Fernhall, 2011; Endemann and 
Schiffrin, 2004; Eckers and Haendeler, 2015). Endothelial cells accomplish these 
actions by responding to both chemical and physical stimuli (blood flow [i.e. shear 
stress] and pressure), producing myriad substances and releasing them into the 
bloodstream or underlying vascular smooth muscle cells (Endemann and Schiffrin, 
2004). Further, endothelial cells are adaptable to their environment; there is evidence 
of vast endothelial heterogeneity between and within different vascular beds 
throughout the body (Aird, 2012). Endothelial cells are highly mutable under 
conditions such as exercise training (Padilla et al., 2011) or exposure to CVD risk 
factors (Deanfield, Halcox, and Rabelink, 2007). 
 
Endothelial damage and dysfunction 
Damage to the endothelium and excessive exposure to CVD risk factors alters 
the endothelial cell phenotype and hampers its ability to appropriately respond to 
stimuli (Versari et al., 2009). A state of endothelial dysfunction results, in which the 
endothelium loses its protective abilities and adopts pro-atherogenic characteristics. 
This switch reflects the activation of a defense response, whereby endothelial cells 




The most notable functional characteristic is impaired endothelium-dependent 
vasodilation due to reduced bioavailability of vasodilators, primarily nitric oxide 
(NO), combined with increased expression of vasoconstricting agents (Bonetti et al., 
2002).  
Endothelial dysfunction was first described in humans by Ludmer et al., who 
showed impaired endothelium-dependent vasodilation of coronary arteries with 
atherosclerosis (1986). Panza and colleagues later observed reduced dilation in the 
forearms of hypertensive patients (1990). Furthermore, endothelial dysfunction 
precedes CVD development (Taddei et al., 1996), and endothelial function is 
inversely correlated with the number of CVD risk factors present (Vita et al., 1990). 
In a prospective study, Halcox et al. showed that endothelial dependent function of 
coronary arteries was a strong predictor of future cardiovascular events in subjects 
with and without coronary artery disease (CAD) (2002). Thus, it has been proposed 
that endothelial function could serve as a barometer of CVD risk, since endothelial 
dysfunction represents the initial step towards atherogenesis (Vanhoutte, 2010). 
Importantly, endothelial dysfunction appears also to be involved in the later stages of 
atherosclerotic lesion progression (Vita and Keaney, 2002).  
Maintenance of an intact endothelial cell monolayer is vital to normal 
functioning of blood vessels, so injury to the endothelial cell layer is an important 
initiating event in endothelial dysfunction (Ross et al., 1977; Vanhoutte, 2009). Injury 
may stem from prolonged and/or repeated exposure to a variety of different stimuli, 
such as CVD risk factors (e.g dyslipidemia, smoking, hyperglycemia, aging, 




and/or mechanical factors (Ross et al., 1977; Deanfield et al., 2007; Eckers and 
Haendeler, 2015; Vanhoutte, 2010; Woywodt et al., 2002). Under normal, healthy 
conditions, endothelial cells are in a quiescent state and endothelial turnover occurs at 
a slow rate. With aging, endothelial cell apoptosis and turnover increase, a process 
which is accelerated by the presence of CVD risk factors (Vanhoutte, 2010; 
Vanhoutte, 2009). Thus, injurious agents can lead not only to endothelial cell 
dysfunction, but also compromised integrity of endothelial cells, apoptosis or 
senescence, and eventual detachment from the endothelium (Deanfield et al., 2007; 
Ross et al., 1977).  
The mechanism(s) of endothelial denudation are not well understood, though 
alterations in blood flow, loss of contact with neighboring cells, integrins, 
neutrophils, cytokines, and proteases may all play a role (Ballieux et al., 1994; 
Woywodt et al., 2002; Ross et al., 1977). Sites of denudation are then susceptible to 
platelet adhesion to the sub-endothelial layer which cause vasoconstriction and 
subsequent smooth muscle cell migration and proliferation (Ross et al., 1977; 
Vanhoutte, 2009). Restoration of the endothelial monolayer is possible if the injury 
and its response are limited. However, repeated cycles of this process over a period of 
years leads to the accumulation and invasion of proliferated smooth muscle cells into 
the lumen (Ross et al., 1977). At this point, endothelial dysfunction results and an 
atherosclerotic lesion is initiated, as the mechanisms of repair and lesion regression 






Endothelial repair by migration 
Damage to the endothelium is dependent on the balance between injury and 
repair. Regeneration of the endothelial monolayer is achieved by neighboring 
endothelial cells adjacent to the damaged area, though more recently circulating 
endothelial progenitor cells (EPCs) have been shown as an alternative mechanism 
(Ettenson and Gotlieb, 1993; Asahara et al., 1997). It has been postulated that under 
healthy conditions in the absence of risk factors, the endogenous repair mechanisms 
of adjacent endothelial cells would be sufficient to maintain endothelial integrity 
throughout life (Deanfield et al., 2007). Endogenous repair is achieved primarily by 
migration of adjacent endothelial cells into the site of injury, followed by 
proliferation. Proliferation is both preceded by and dependent on prior migration 
(Coomber and Gotlieb, 1990; Gotlieb and Lee, 1999). Further, migration, as opposed 
to proliferation, appears to be the major mechanism responsible for wound healing in 
vitro, at least in the initial 1-2 days following injury (Li et al., 2005). In response to 
denudation of an area of the endothelium, adjacent endothelial cells transition from a 
quiescent state to one which promotes migration. This process relies heavily on 
microfilament/cytoskeleton reorganization and involves the reduction of cell-cell 
adhesion with neighboring cells, elongation, cell spreading, and translocation (Gotlieb 
and Lee, 1999). Once the wounded area is covered and the endothelium monolayer is 







Shear stress modulates endothelial repair 
Cytoskeletal reorganization, and by extension migration, is moderated by 
hypercholesteremia, altered shear stress, growth factors (e.g. VEGF, bFGF, 
angiopoietins), and other soluble factors (Gotlieb and Lee, 1999; Dimmeler et al., 
2000; Lamalice et al., 2007). Endothelial cells that regenerate a wounded area in the 
presence of risk factors may exhibit altered phenotypes, resulting in local endothelial 
dysfunction and predisposing the area to atherogenesis (Vanhoutte, 2010). 
Conversely, elevated levels of shear stress induce enhanced wound repair and 
atheroprotective effects (Cunningham and Gotlieb, 2005).  Shear stress refers to the 
frictional force exerted by the parallel flow of blood along the vascular wall 
(Cunningham and Gotlieb, 2005). Vascular shear stress exerts direct forces on the 
endothelium and is important in modulating endothelial cell structure and function. 
Endothelial cells respond to shear-induced mechanotransduction by altering gene 
expression, cytoskeletal organization, and secreted factors (Cunningham and Gotlieb, 
2005; Li et al., 2005; Boon et al., 2012). Notably, each step in the process of 
endothelial cell migration is influenced by shear stress (Li et al., 2005). Both in vivo 
and in vitro studies have shown that shear stress can beneficially enhance endothelial 
cell migration and wound healing (Wu et al., 1995; Albuquerque et al., 2000). The 
importance of shear stress is emphasized by the fact that vascular sites of altered 
and/or decreased shear, such as arterial branching and curving points, are usually the 
sites of endothelial denudation and are significantly more likely to develop 




increases in shear stress, as is seen with repeated bouts of exercise, favorably 
augments vascular function and remodeling (Tinken et al., 2010). 
  
Beneficial cardiovascular effects of exercise training 
 Exercise training induces beneficial cardiovascular system adaptations in 
young and old, healthy and diseased populations. Cardiovascular adaptations are 
greatest with aerobic, endurance type activities as opposed to strength training 
(Hurley et al., 1984). Structural and functional changes to the heart, vasculature, and 
blood due to repeated bouts of aerobic exercise, combine to improve functional 
capacity and endurance. Further, physical inactivity is a major risk factor for CVD 
(Morris et al., 1953). Regular physical activity protects against CVD, with the most 
active individuals showing up to a 40% reduction in risk (Shiroma and Lee, 2010). 
Still, even greater reductions in risk are seen with increases in cardiorespiratory 
fitness (Williams, 2001). Regular physical activity is effective in prevention and 
treatment of the modifiable CVD risk factors and, by extension, atherosclerosis 
(Thompson et al., 2003). Moreover, exercise training and rehabilitation are effective 
therapies for CVD patients. Exercise training has been shown to reduce symptoms, 
enhance quality of life, and/or reduce mortality rates in patients with MI, CAD, CHF, 
angina, peripheral arterial disease, and claudication (Thompson et al., 2003). 
Specific physiological adaptations to endurance training include increased 
aortic compliance (Mohiaddin et al., 1989), improved ventricular performance 
(Moore and Korzick, 1995), augmented myocardial (Brown, 2003) and skeletal 




and compliance (Brown, 2003; Vaitkevicius et al., 1993), enhanced number and size 
of mitochondria (Hoppeler et al., 1973), increased oxidative enzyme content 
(Holloszy, 1967), expanded plasma volume (Fellman, 1992), and improved 
endothelial function (Hambrecht et al., 2003). Additionally, exercise training is able 
to reverse endothelial dysfunction in young and old adults (DeSouza et al., 2000). 
Such changes in vascular function are not explained solely by exercise training-
mediated effects on classic CVD risk factors (Green et al., 2003).  
There is ample evidence to suggest shear stress as the major mechanism 
responsible for training-induced endothelial and vascular adaptations (Tinken et al., 
2010; Di Francescomarino et al., 2009). Shear stress alters endothelial cell 
phenotypes via direct mechanotransduction-mediated effects (Cunningham and 
Gotlieb, 2005). Intriguingly, similar adaptations have been observed in vasculature 
perfusing skeletal muscles and organs that are inactive during exercise and, therefore, 
do not experience a significant degree of increased shear stress (Padilla et al., 2011). 
This suggests that other systemic mechanism(s) besides shear stress, such as other 
hemodynamic or circulating factors, may also be in effect. In addition, studies show 
that the amount of shear stress experienced by endothelial cells affects microRNA 
(miRNA) expression and secretion into the circulation, which may be taken up by 
other endothelial cells (Weber et al., 2010; Hergenreider et al., 2012).   
 
MiRNAs 
 MiRNAs are ~22 nucleotide long, non-coding RNAs that control gene 




nematode Caenorhabditis elegans (C. elegans) by Lee, Feinbaum, and Ambros in 
1993. They, along with Ruvkun’s group, reported that the small lin-4 RNA could base 
pair with a section of the 3’ untranslated region (3’UTR) of another RNA, lin-14, and 
downregulate abundance of the LIN-14 protein (Lee et al. 1993; Wightman, Ha, and 
Ruvkun, 1993). In 1998, Fire and colleagues demonstrated the potential of 
experimental RNA interference when they introduced a small, double-stranded RNA 
into C. elegans and observed potent downregulation of endogenous target mRNA. 
The field of miRNA research has since grown immensely and the miRNA pathway is 
now known to be highly conserved in mammals (Saetrom et al., 2006; Friedman et 
al., 2008). There are currently 2588 identified miRNAs in the human genome and it is 
predicted that over 60% of protein coding-genes are conserved targets (Kozomara and 
Griffiths-Jones, 2014; Friedman et al., 2008). Furthering their complexity, individual 
miRNAs usually regulate several, in some cases up to 200, mRNA transcripts, while 
multiple miRNAs can share the same mRNA target (Esquela-Kerscher and Slack, 
2006). Another characteristic of miRNAs is tissue specific expression and function, 
which are sometimes contradictory. For instance, miR-26 acts as a tumor suppressor 
in liver and intestinal cancers, and as an oncogene in brain cancer (Kota et al., 2009; 
Zeitels et al., 2014; Huse et al., 2009). Thus, miRNAs act in a highly coordinated and 
intricate fashion to fine-tune protein expression. 
 
Canonical miRNA biosynthesis 
MiRNA genes are transcribed by polymerase II into an initial primary miRNA 




sequence in a stem-loop structure. Genes for miRNAs are encoded in both intergenic 
and intronic regions, and they are often found in polycistronic transcription units (Ha 
and Kim, 2014). Interestingly, many miRNAs encoded within intronic regions repress 
their co-transcribed host gene(s) (Ramalingam et al., 2013). Further, intronic miRNAs 
also have their own promoters, which allows independent transcription and distinct 
expression from their host gene(s) (Ramalingam et al., 2013).  
The nuclear enzyme Drosha cleaves the pri-miRNA into a ~65 bp pre-
miRNA. This double stranded hairpin structure associates with Exportin-5 and is 
transported through a nuclear pore into the cytoplasm. Here, the pre-miRNA is further 
cleaved by Dicer near its terminal loop, resulting in a 21-25 bp double stranded RNA 
consisting of the mature miRNA and its complimentary strand. The miRNA duplex is 
quickly unwound and is loaded onto an Argonaute protein, associated with Dicer, to 
form a miRNA-induced silencing complex (miRISC) (Siomi and Siomi, 2009; 
Carthew and Sontheimer, 2009). The strand that associates with RISC is the mature 
miRNA, which acts as a guide by complimentarily binding to the 3’-untranslated 
region of the target mRNA transcript (Ha and Kim, 2014). The associated ‘passenger’ 
strand is most often released into the cytoplasm and degraded (Siomi and Siomi, 
2009). Nucleotides 2 to 8 on the 5’ end of the mature miRNA are most important in 
target recognition and binding (Esquela-Kerscher and Slack, 2006). The mRNA 
targeted by miRISC may be perfectly or imperfectly complementary, having 
implications on the mechanism of silencing that affects the target mRNA transcript. 
This capability for imperfect binding is also important in that it allows an individual 




completely downregulates gene expression by inducing either translational 
repression, mRNA deadenylation, mRNA degredation, or sequestration in processing-
bodies (P-bodies) (Jackson and Standart, 2007). Further complicating matters, more 
recent studies have provided evidence that miRNA-mediated up-regulation of 
transcription may also occur under certain conditions (Orang, Safaralizadeh, and 
Kazemzadeh-Bavili, 2014). 
 
Circulating-miRNAs as biomarkers of disease 
 The fine-tuning of gene expression by miRNAs is crucially important in 
biological processes such as cell growth, cell proliferation, tissue differentiation, 
embryological development, apoptosis, and motility (Wilson and Doudna, 2013; Lu 
et al., 2008). Owing to their importance, the number of miRNAs in the genome 
correlates with complexity of the organism (Berezikov, 2011). Accordingly, miRNAs 
are found in seemingly all cell types and compartments of the body. Specifically, the 
fairly recent discovery of miRNAs in biofluids, including serum, plasma, saliva, 
urine, and milk, has opened up new possibilities for miRNA research (Chen et al., 
2011). Such circulating miRNAs (ci-miRNAs) are secreted into the circulation either 
passively or actively. They circulate in association with microvesicles (exosomes or 
apoptotic bodies), proteins (Argonaute), or HDL. Ci-miRNAs can then be actively 
taken up by target recipient cells where they prompt downstream effects (Zhang et al., 
2010; Hergenreider et al., 2012). 
It is unsurprising that dysregulation of miRNAs underlies numerous 




diseases, including cancers, neurological disorders, metabolic diseases, 
neuromuscular diseases, viral pathologies, liver diseases, pulmonary diseases, CVDs, 
and more (Lu et al., 2008; Hammond, 2015; Fiorillo et al., 2015; Lanford et al., 2010; 
Haider et al., 2014). Consequently, ci-miRNAs have been proposed as useful 
biomarkers of disease since they are easily acquired, highly stable, and conveniently 
amplifiable. Ci-miRNA disease biomarkers have been extensively investigated, while 
the potential therapeutic value of ci-miRNA based interventions is also clear. In 2010, 
Lanford et al. demonstrated long-term suppression of the hepatitis C virus in 
chimpanzees by intravenous infusion of a complimentary antagonist to miR-122. This 
treatment is now in phase 2 clinical trials and other miRNA therapies are in 
preclinical development for diseases such as CHF and MI (Bader and Lammers, 
2011). 
 
MiRNAs in cardiovascular physiology and pathophysiology 
  MiRNAs appear to play roles in regulating essentially all cardiovascular cell 
types, processes, and diseases. Studies have revealed roles for miRNAs in the 
development and function of endothelial cells, vascular smooth muscle cells, 
cardiomyocytes, early EPCs, and other cardiovascular related stem/progenitor cells 
(Jakob and Landmesser, 2011). In the first study signifying the importance of 
miRNAs in cardiovascular development, Yang et al. developed mice lacking Dicer, a 
critical enzyme in the miRNA biosynthesis pathway (2005). Dicer deficiency was 
embryonically fatal and embryos displayed defective vessel formation/maintenance 




physiological and pathological angiogenesis (Finn and Searles, 2012). For example 
systemic injection of a miR-26a antagonist in mice with experimentally induced MI 
significantly increased myocardial angiogenesis and decreased myocardial infarct size 
(Icli et al., 2015). Conversely, overexpression of miR-26a reduced skeletal muscle 
angiogenesis in mice undergoing exercise training (Icli et al., 2015). Feng et al. 
provided evidence that miR-487b enhances HUVEC migration and angiogenesis 
(2015). They further showed that ci-miR-487b is up-regulated in plasma of ischemic 
stroke patients, representing a possible option for therapeutic intervention. 
The involvement of ci-miRNAs in CVD pathologies has been extensively 
detailed (Bronze-da-Rocha, 2014). Further, altered ci-miRNA profiles are associated 
with CVD risk factors, such as hypertension, diabetes, hyperglycemia, dyslipidemia, 
aging and smoking (Mcmanus and Ambros, 2011; Jansen et al., 2013; Varga et al., 
2013; Bronze-da-Rocha, 2014; Takahashi et al., 2013). As opposed to passive release 
due to cell damage or senescence, which may happen in some cases (e.g. miR-1 
following MI) (Bronze-da-Rocha, 2014), the majority of evidence suggests deliberate 
packaging and release of miRNAs as a form of intercellular communication 
(Hergenreider et al., 2012). In 2010, Zhang et al. showed that monocyte secreted 
microvesicles containing miRNA are taken up by endothelial cells in vitro, where 
transferred miR-150 is then responsible for stimulating and enhancing migration. 
Exosomes secreted by CD34+ stem cells are also taken up by endothelial cells and 
account for their proangiogenic paracrine activity (Sahoo et al., 2011). These 





Endothelial cells secrete microvesicles of their own, which may be 
incorporated into vascular smooth muscle cells or other endothelial cells. For 
instance, in response to shear stress in vitro, endothelial cells secrete exosomes 
containing miRs-143 and 145 which are transferred to the underlying smooth muscle 
where they regulate gene expression to confer atheroprotective effects (Hergenreider 
et al., 2012). Endothelial cells also release miR-126 in microparticles, which is taken 
up by recipient endothelial cells in vivo and promotes repair of injured sites by 
stimulating migration and proliferation (Jansen et al., 2013). Microparticles from 
serum of diabetic patients exhibited reduced miR-126 content, which is likely 
associated with decreased capacity for endothelial repair (Jansen et al., 2013). 
Further, in a setting of atherosclerosis, damaged endothelial cells secrete apoptotic 
bodies containing miR-126 (Zernecke et al., 2009). Secreted apoptotic bodies act to 
recruit EPCs, protect neighboring endothelial cells, and stabilize plaques, largely 
through miR-126-mediated gene regulation (Zernecke et al., 2009). These studies 
help to emphasize the potential of ci-miRNA based interventions to combat 
atherosclerosis.  
MiRNAs are, in fact, involved in every stage of atherosclerosis, from 
endothelial dysfunction to cholesterol homeostasis and transport, inflammation, and 
finally plaque development and rupture (Madrigal-Matute et al., 2013). In 2014, 
Loyer et al. showed that anti-miR-92a treatment in ldlr knockout mice fed a high-fat 
diet successfully reduced atherosclerotic lesions, led to more stable plaque 
composition, and decreased endothelial inflammation. MiR-92a is active in early 




HUVEC migration and proliferation in vitro, and increased NO production (Iaconetti 
et al., 2012). More importantly, inhibition of miR-92a significantly improved re-
endothelialization and reduced neointimal lesion formation following both carotid 
artery balloon injury and stenting in rats (Iaconetti et al., 2012). In addition to those 
previously mentioned, other moderators of wound closure by altered endothelial cell 
migration include miRs-21, 23, 27, 20a, and 196a (Sabatel et al., 2011; Zhou et al., 
2011; Pin et al., 2012; Pin et al., 2012b) Thus, the processes of endothelial cell 
migration and wound healing are highly regulated by a variety of miRNAs. 
Interestingly, shear stress modulates miRNAs involved in migration and other 
endothelial cell processes.   
 
Shear stress modulates endothelial miRNAs  
Shear stress has long been known to beneficially improve wound healing by 
enhanced endothelial cell migration in vitro and in vivo (Albuquerque et al., 2000; 
Vyalov, Langille, and Gotlieb, 1996). This finding stems from the fact that 
atherosclerotic lesions and areas of endothelial damage most often occur in arterial 
regions of altered/reduced shear (Cunningham and Gotlieb, 2005). Interestingly, 
Loyer at al. observed increased miR-92a expression in the atheroprone aortic arch as 
compared to the descending thoracic aorta in normocholesterolemic mice, and in the 
downstream sections of human carotid plaques, which experience low shear stress as 
compared to upstream sections (2014). Qin et al. were the first to describe the 
phenomenon of altered miRNA expression in endothelial cells due to shear stress in 




miRNAs and downregulate atheroprone miRNAs (Boon et al., 2012). Specifically, 
miR-126 is upregulated in HUVECs exposed to laminar shear stress and subsequently 
regulates target mRNA expression in favor of an atheroprotective phenotype 
(Mondadori et al., 2015). Shear stress increases miR-21 expression in HUVECs, 
decreasing apoptosis and increasing NO production (Weber et al., 2010). 
Paradoxically, under conditions with no flow or shear stress, miR-21 impairs HUVEC 
migration and angiogenesis (Sabatel et al., 2011). These results may be reconciled by 
the fact that miR-21 has different effects depending on the degree and mode of shear 
stress (Neth et al., 2013). In addition to altering intracellular miRNA expression, 
shear stress regulates the secretion of ci-miRNAs. Jae et al. recently showed that 
shear stress-responsive transcription factor KLF2 induces selective packaging and 
export of miRNAs that is independent of intracellular levels of up-regulation (2015). 
They further detailed the KLF2 induced exosomal pathway responsible for the 
secretion of miRs-143 and 150 (Jae et al., 2015).  
 
Exercise training alters miRNAs and circulating factors  
Several studies have described the altered characteristics of serum and 
circulating factors, including ci-miRNAs, in response to either acute exercise or 
training. Following an aerobic exercise training program, CHF and CAD patients 
displayed increases in beneficial serum proteins important to cardiac vascular 
remodeling (Gatta et al., 2012). Furthermore, when serum obtained after training was 
applied to healthy PBMCs, it beneficially increased colony forming units-endothelial 




exercise training in CHF patients significantly reduced serum capacity to induce 
release of lactate dehydrogenase and DNA fragmentation in HUVECs, signs of cell 
death and apoptosis respectively (Mammi et al., 2011). More recently, HDL isolated 
from CHF patients was co-cultured with human aortic endothelial cells. Compared to 
HDL from healthy controls, CHF HDL induced significantly less endothelial 
expression of pro-angiogenic miRs-126, 21, and 222 (Riedel et al., 2015). This 
difference was attenuated following a moderate exercise training program (Riedel et 
al., 2015). In pre-diabetic individuals, serum ci-miRs-192 and 193 are elevated as 
compared to diabetic and healthy subjects (Parrizas et al., 2015). Following an 
exercise training intervention, prediabetic subjects exhibited healthy fasting glucose 
levels and ci-miRs-192 and 193 returned to baseline levels (Parrizas et al., 2015). 
Surprisingly, at rest, the circulating levels of several angiogenic factors, such 
as VEGF, appear to be unaffected by endurance exercise training status (Kraus et al., 
2004; Landers-Ramos et al., 2014; Lamalice et al., 2007). On the other hand, 
differential expression of plasma miRNAs occurs following an acute bout of cycling, 
as well as after aerobic exercise training (Baggish et al., 2011; Nielson et al., 2014). 
Baggish et al. further characterized the ci-miRNA response to an exhaustive bout of 
exercise with the finding that muscle, cardiac, and endothelial specific miRNAs were 
upregulated immediately after a marathon run (2014). Further, they were cleared from 
circulation faster than their respective, traditional tissue-specific biomarkers (e.g. 
troponin I and creatine phosphokinase) (Baggish et al., 2014). Similarly, Sawada and 
colleagues demonstrated that ci-miRNAs exhibit unique time-courses of upregulation 




In 2012, Da Silva et al. demonstrated that cardiac miR-126 and ventricular 
capillary-to-fiber ratio increased in rats as a function of intensity of exercise training. 
This suggested the possibility that miRNAs may play a role in exercise training-
induced cardiovascular adaptations. It has since been shown that unique miRNAs are 
involved in the left ventricular hypertrophy response to aerobic exercise training, 
compared to those active in the pathological hypertrophy response (Soci et al., 2011; 
Martinelli et al., 2014; Ramasamy et al., 2015). Alternatively, systemic injections of 
miR-181c markedly reduced exercise capacity and induced signs of CHF in rats by 
altering mitochondrial function (Das et al., 2014).  
In humans, miR-499 is elevated in active versus sedentary thigh muscle, and 
is associated with increased type 1 fiber percentage (Gan et al., 2013). Furthermore, 
ci-miRNAs that correlate with VO2max, running speed at lactate threshold, and 
thickness of intraventricular septum have been identified (Mooren et al., 2014). As 
might be expected then, plasma ci-miRNAs do differ between endurance and 
strength-trained athletes (Wardle et al., 2015). On the other hand, Backes et al. 
concluded that ci-miRNA expression in whole blood was not significantly different in 
elite athletes v. moderately active controls, although the fact that both groups were 
young, healthy, and aerobically active may have meant these subject groups were too 
similar to see significant differences (2014). Bye and colleagues determined three ci-
miRNAs to be differentially expressed between high and low VO2max groups with 
identical physical activity habits and CVD risk factors (2013). This suggests a 
possible genetic basis for ci-miRNA expression divergence, as they also found 





MiRNAs represent important regulators of cardiovascular health and disease. 
Further, ci-miRNAs are extensively reported as biomarkers of disease and systemic 
miRNA therapies are becoming more common. Based on the literature, the potential 
use of miRNA interventions in prevention and treatment of CVDs is vast and 
compelling. Specifically, numerous miRNAs are involved in wound-healing of the 
endothelium and in vivo studies offer glimpses of their practical importance. 
Furthermore, miRNAs at least partially mediate many long-established cardiovascular 
benefits of exercise training. Thus, exercise training represents a powerful model for 
elucidating novel miRNA pathways relevant to CVD interventions. Evidence of 
altered circulating and intracellular miRNAs and their targets also provides further 
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